LabGenius Company
LabGenius is a biopharmaceutical company developing protein therapeutics using a machine learning-driven evolution engine. Its protein engineering platform integrates several bleeding-edge technologies from the fields of machine learning, synthetic biology, and robotics.
Investors
(INV).png)
.png)
.png)
.png)
.png)
.png)
.png)
Technology:
Artificial Intelligence, Biotechnology, Machine Learning, Robotics, Therapeutics
Industry:
Early Drug Development
Headquarters:
London, England, United Kingdom
Founded Date:
2012-09-01
Employees Number:
51-100
Funding Status:
Early Stage Venture
Investors Number:
19
Total Funding:
28660000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2020-10-30
Last Funding Type:
Series A
Register and Claim Ownership